Drug Search Results
More Filters [+]

Delcasertib

Alternative Names: delcasertib, kai-9803
Latest Update: 2011-09-02
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PKC Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Amgen
Company Location: THOUSAND OAKS CA 91320
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Delcasertib

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: ST Elevation Myocardial Infarction|Myocardial Infarction

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

PROTECTION AMI

P2

Completed

Myocardial Infarction

2011-05-25

PROTECTION AMI

P2

Completed

ST Elevation Myocardial Infarction

2010-07-01

DELTA MI

P2

Completed

ST Elevation Myocardial Infarction

2006-11-28

KAI-9803-001

P2

Completed

ST Elevation Myocardial Infarction

2006-10-01

Recent News Events

Date

Type

Title